| Autoantibodies against type I IFNs in patients with life-threatening COVID-19 P Bastard, LB Rosen, Q Zhang, E Michailidis, HH Hoffmann, Y Zhang, ... Science 370 (6515), eabd4585, 2020 | 2432 | 2020 |
| Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 Q Zhang, P Bastard, Z Liu, J Le Pen, M Moncada-Velez, J Chen, M Ogishi, ... Science 370 (6515), eabd4570, 2020 | 2121 | 2020 |
| Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ... Science immunology 6 (62), eabl4340, 2021 | 433 | 2021 |
| X-linked recessive TLR7 deficiency in~ 1% of men under 60 years old with life-threatening COVID-19 T Asano, B Boisson, F Onodi, D Matuozzo, M Moncada-Velez, ... Science immunology 6 (62), eabl4348, 2021 | 325 | 2021 |
| Acute myocardial infarction in hospitalized patients with community-acquired pneumonia J Ramirez, S Aliberti, M Mirsaeidi, P Peyrani, G Filardo, A Amir, B Moffett, ... Clinical infectious diseases 47 (2), 182-187, 2008 | 250 | 2008 |
| Gains of glycosylation comprise an unexpectedly large group of pathogenic mutations G Vogt, A Chapgier, K Yang, N Chuzhanova, J Feinberg, C Fieschi, ... Nature genetics 37 (7), 692-700, 2005 | 245 | 2005 |
| Racial difference in sarcoidosis mortality in the United States M Mirsaeidi, RF Machado, D Schraufnagel, NJ Sweiss, RP Baughman Chest 147 (2), 438-449, 2015 | 214 | 2015 |
| Thrombocytopenia and thrombocytosis at time of hospitalization predict mortality in patients with community-acquired pneumonia M Mirsaeidi, P Peyrani, S Aliberti, G Filardo, J Bordon, F Blasi, JA Ramirez Chest 137 (2), 416-420, 2010 | 212 | 2010 |
| COVID-19 clinical characteristics, and sex-specific risk of mortality: systematic review and meta-analysis MJ Nasiri, S Haddadi, A Tahvildari, Y Farsi, M Arbabi, S Hasanzadeh, ... Frontiers in medicine 7, 459, 2020 | 182 | 2020 |
| Nontuberculous mycobacterial disease mortality in the United States, 1999–2010: a population-based comparative study M Mirsaeidi, RF Machado, JGN Garcia, DE Schraufnagel PloS one 9 (3), e91879, 2014 | 179 | 2014 |
| Climate change and respiratory infections M Mirsaeidi, H Motahari, M Taghizadeh Khamesi, A Sharifi, M Campos, ... Annals of the American Thoracic Society 13 (8), 1223-1230, 2016 | 177 | 2016 |
| Incidence, etiology, timing, and risk factors for clinical failure in hospitalized patients with community-acquired pneumonia S Aliberti, A Amir, P Peyrani, M Mirsaeidi, M Allen, BK Moffett, J Myers, ... Chest 134 (5), 955-962, 2008 | 173 | 2008 |
| The roles of miRNAs as potential biomarkers in lung diseases SD Alipoor, IM Adcock, J Garssen, E Mortaz, M Varahram, M Mirsaeidi, ... European journal of pharmacology 791, 395-404, 2016 | 165 | 2016 |
| Plasma free hemoglobin is an independent predictor of mortality among patients on extracorporeal membrane oxygenation support HR Omar, M Mirsaeidi, S Socias, C Sprenker, C Caldeira, EM Camporesi, ... PloS one 10 (4), e0124034, 2015 | 155 | 2015 |
| Rituximab in the treatment of refractory pulmonary sarcoidosis NJ Sweiss, EE Lower, M Mirsaeidi, S Dudek, JGN Garcia, D Perkins, ... European Respiratory Journal 43 (5), 1525-1528, 2014 | 146 | 2014 |
| Non-tuberculous mycobacterial disease is common in patients with non-cystic fibrosis bronchiectasis M Mirsaeidi, W Hadid, B Ericsoussi, D Rodgers, RT Sadikot International Journal of Infectious Diseases 17 (11), e1000-e1004, 2013 | 143 | 2013 |
| Exosomes and exosomal miRNA in respiratory diseases SD Alipoor, E Mortaz, J Garssen, M Movassaghi, M Mirsaeidi, IM Adcock Mediators of inflammation 2016, 2016 | 142 | 2016 |
| Lung health in era of climate change and dust storms MD Schweitzer, AS Calzadilla, O Salamo, A Sharifi, N Kumar, G Holt, ... Environmental research 163, 36-42, 2018 | 133 | 2018 |
| The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies J Manry, P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, ... Proceedings of the National Academy of Sciences 119 (21), 2022 | 127 | 2022 |
| Annexins family: insights into their functions and potential role in pathogenesis of sarcoidosis M Mirsaeidi, S Gidfar, A Vu, D Schraufnagel Journal of translational medicine 14, 1-9, 2016 | 126 | 2016 |
Abdolrazagh Hashemi Shahraki, Lead...College of Medicine-Jacksonville, University of Florida, USAVerified email at ufl.edu
